Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of the Effects of IV Ketorolac on Platelet Function Post-Cesarean Delivery

NCT03805607 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.

NCT NCT03805607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03805607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of the Effects of IV Ketorolac on Platelet Function Post-Cesarean Delivery
Lead sponsor
Beth Israel Deaconess Medical Center
Phase
Phase 4
Overall status
Completed
Start date
January 18, 2021
Completion date
March 30, 2024
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

analgesia, obstetrical, blood loss, postoperative, coagulation defect; postpartum, ketorolac adverse reaction, nonsteroidals (nsaids)toxicity, postoperative pain, postpartum hemorrhage